CARRIE CAMPBELL: Open Payments
NPI 1629741913 · BRUNSWICK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 64 payments from 15 companies in 2025. Trend: 2023 $154 · 2024 $474 · 2025 $1,049
Food & beverage: $995Education: $54
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $498 |
| Ardelyx, Inc. | 5 | $84 |
| Janssen Biotech, Inc. | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 6 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Madrigal Pharmaceuticals | 2 | $42 |
| PFIZER INC. | 2 | $35 |
| GENZYME CORPORATION | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: RINVOQ, SKYRIZI, IBSRELA, TREMFYA, VOQUEZNA, ENTYVIO, XIFAXAN, DUPIXENT.
Industry payments across OH — which companies pay providers there.
